DarioHealth Corp.

NASDAQ:DRIO

Medical - Diagnostics & Research

Healthcare
$5.13 -1.68%

-$0.12 today

Market cap
$50.27M
Beta
1.08
P/E (TTM)
5.5
EPS (TTM)
$1.26
52W Low $5.94High $17.74

Volume 0.01M

Average 0.01M

DRIO Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

DarioHealth Corp.NASDAQ: DRIO

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) grows, but more slowly than its trailing trend

Q1 FY2026 weighted avg shares (diluted) of 49.63M shares rose 10.2% year over year, behind the +19.8% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 0.0% from the prior quarter. Over 3 fiscal years it compounded at +28.1% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +10.2% toward the trailing-twelve-month pace of +19.8%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
49.63M+0.0% QoQ
Last fiscal yearDec 2025
49.63M+22.8% YoY
LTMMar 2026
49.63M+19.8% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+10.2%——
1 year+22.8%——
3-year CAGR+28.1%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
49.63M USD
Year-over-year change
+22.8%
4-year CAGR
+31.5%

Weighted Avg Shares (Diluted) vs competitors

How DRIO compares with its peers on the latest reported figures

  • DRIO's LTM Mar 2026 weighted avg shares (diluted) of 49.63M shares is the 7th highest of the 11 companies compared; the peer median is 67.14M shares.
  • Its year-over-year change of +19.8% is the 3rd highest of 11, against a peer median of +2.9%.
  • Over three fiscal years its annual growth of +28.1% compares with a peer median of +5.6%.
DRIO Competitors Peer median
Weighted Avg Shares (Diluted) for DRIO and competitors
Company Period LTM YoY 3-year CAGR
PACBPacific Biosciences of California, Inc.LTM Mar 2026302.18M +5.2%+10.1%
ABSIAbsci CorporationLTM Mar 2026143.73M +23.4%+14.6%
INNVInnovAge Holding Corp.LTM Mar 2026135.61M +0.0%-0.0%
MYGNMyriad Genetics, Inc.LTM Mar 202693.15M +2.4%+5.0%
VSTMVerastem, Inc.LTM Mar 202682.44M +107.0%+62.5%
RGNXREGENXBIO Inc.LTM Mar 202651.84M +1.8%+6.1%
DRIODarioHealth Corp.LTM Mar 202649.63M +19.8%+28.1%
AVNSAvanos Medical, Inc.LTM Mar 202646.5M +0.2%-0.6%
NNNNAnbio Biotechnology Class A Ordinary SharesFY202543.89M +3.8%-32.7%
OFIXOrthofix Medical Inc.LTM Mar 202639.93M +3.4%+25.7%
FLGTFulgent Genetics, Inc.LTM Mar 202630.81M +1.0%-0.2%
Peer median (excluding DRIO) 67.14M+2.9%+5.6%

Competitors are the stored peer set for DRIO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue20.51M27.66M20.35M27.04M22.36M
Cost of Revenue12.44M18M14.37M13.77M9.69M
Gross Profit8.07M9.66M5.98M13.27M12.67M
Gross Margin39.3%34.9%29.4%49.1%56.6%
Research & Development17.22M19.65M20.25M24.18M13.79M
Selling, General & Admin62.36M46.82M41.8M46.83M35.53M
Operating Expenses84.56M66.47M62.17M71.01M49.32M
Depreciation & Amortization4.46M4.72M4.99M7.43M3.56M
EBITDA(70.02M)(55.6M)(54.38M)(37.08M)(34.69M)
EBITDA Margin-341.3%-201.0%-267.2%-137.1%-155.2%
Operating Income(76.49M)(56.81M)(56.19M)(57.74M)(36.66M)
Operating Margin-372.9%-205.4%-276.1%-213.6%-163.9%
Interest Income44K506K1.87M1.12M943K
Interest Expense84K2.68M645K96K3.36M
Other Income / Expenses(235K)(5.38M)(3.17M)13.15M(4.95M)
Income Before Tax(76.73M)(62.19M)(59.36M)(44.6M)(41.61M)
Pre-Tax Margin-374.1%-224.9%-291.7%-164.9%-186.1%
Income Tax Expense32K4K64K(1.85M)105K
Net Income(76.76M)(62.19M)(59.43M)(42.75M)(41.71M)
Net Margin-374.2%-224.9%-292.0%-158.1%-186.6%
EPS (Basic)(4.63)(2.63)(1.93)(0.74)1.24
EPS (Diluted)(4.63)(2.63)(1.93)(0.74)1.24
Weighted Avg Shares16.59M23.64M28.37M40.42M49.63M
Weighted Avg Shares (Diluted)16.59M23.64M28.37M40.42M49.63M

DarioHealth Corp.

NASDAQ:DRIO

Intrinsic Alpha fair value

Locked

Current Price

$5.13

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.